65,437 trials
Papulopustular Rosacea
Primary: Investigator's Global Assessment (IGA) Treatment Success Compared to Placebo. — 74; 22 Participants
Overweight · Obesity
Primary: Percent Change in Body Weight From Baseline to 12 Weeks — 9.4; 0.6 percent change
Myopia · Myopic Astigmatism
Primary: Elevated Intraocular Pressure (IOP) in Primary Eyes ≥ 30 mmHg — 15 Eyes
Papulopustular Rosacea
Primary: Investigator's Global Assessment (IGA) Treatment Success Compared to Placebo. — 79; 25 Participants
Acquired Hemophilia A
Primary: Percentage of Participants With Severe Bleeding Episodes Who Demonstrated Response to TAK-672 Therapy at 24 Hours After the Initiation of Treatment — 100 percentage of…
Influenza
Primary: Number of Patients Who Self-scheduled a Flu Shot — 43; 63; 62; 74 Participants — p=.003
Malaria
Primary: The Activity of Single Oral Doses of MMV533 (Name of Investigational Medicinal Product) on Clearance of Plasmodium — 42.17; 158.03; 187.57 PRR48=parasite reduction ratio…
Hepatitis C
Primary: Observed Percentage of Patients in Both Arms Who Achieve Viral Eradication — 106; 246 Participants
Smoking Cessation
Primary: Number of Participants Abstinent From Vaping at Week 8 — 9; 6 Participants
Myocardial Ischemia
Primary: Number of Participants With Diagnostic Consistency When Comparing FFR Measurement Between Control Device and Investigational Device — 274 Participants
Diabetes Mellitus (DM)
Primary: Change in Metatarsal Phalangeal Joint Angle (Degrees) in People With Diabetes From Baseline and at a 3-year Period — 0.8; -0.1 degrees
Breast Cancer
Primary: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] — 0 Participants
Pain, Postoperative · Opioid Use · Recruitment
Primary: Number of Patients Who Receive Bilateral, Pre-incision ESPB — 9; 12 Participants
Dementia, Vascular · Alzheimer Disease · Dementia, Mixed
Primary: Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale [Time Frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)…
Conscious Sedation Failure During Procedure
Primary: Change in Transcutaneous CO2 Pressure — 43.6; 45.6 Unit of Measure "mmHg" — p=0.281